Company: DARE
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0001401914-25-000014
Chunk: 47

Company: Dare Bioscience, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 47
---
 our Board, upon the recommendation of the Compensation Committee, which was based on, and consistent with, Aon's recommendation, which recommendation was based on an assessment of the market data of our peer group.

2025 Proxy Statement | Page 34

### EQUITY COMPENSATION PLAN INFORMATION
The following table sets forth information as of December 31, 2024, with respect to compensation plans (including individual compensation arrangements) under which our equity securities are authorized for issuance. The share numbers and exercise price information in the table below gives effect to the 1-for-12 reverse split of our common stock effected in July 2024.

| Plan Category                                              |     | Number of         
 securities to be  
 issued upon       
 exercise of       
 outstanding       
 options, warrants 
 and rights  (a)   |         |     | Weighted-        
 average exercise 
 price of         
 outstanding      
 options,         
 warrants and     
 rights (b)       |   |        |     | Number of            
 securities remaining 
 available for future 
 issuance under       
 equity               
 compensation plans   
 (c)  (excluding      
 securities reflected 
 in column a))        |         |
| Equity compensation plans approved by security holders(1)  |     |                   | 883,334 |     |                  |   | $14.58 |     |                      | 465,751 |
| Equity compensation plans not approved by security holders |     |                   |       — |     |                  | — |        |     |                      |       — |
| Total                                                      |     |                   | 883,334 |     |                  |   | $14.58 |     |                      | 465,751 |

(1) Consists of securities issued under our Amended and Restated 2014 Stock Incentive Plan and our 2022 Stock Incentive Plan. All such plans are broad-based incentive plans, which allow for the grant of stock options, restricted stock, restricted stock units, stock appreciation rights and other stock-based awards to employees, consultants and non-employee directors.

2025 Proxy Statement | Page 35

### AUDIT COMMITTEE REPORT
The Audit Committee was established in accordance with Section 3(a)(58)(A) of the Exchange Act. The Audit Committee operates under a written charter adopted by our Board. The responsibilities and activities of the Audit Committee are described below and in its charter.

Our Board has determined that each member of the Audit Committee is able to read and understand fundamental financial statements, including our balance sheet, income